The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 347:1719-1721 November 21, 2002 Number 21
NextNext

Insect Repellents and Mosquito Bites

 

This Article
- PDF
-PDA Full Text

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Pollack, R. J.
-Related Article
 by Fradin, M. S.
-PubMed Citation
To the Editor: Fradin and Day's cage study (July 4 issue)1 may be misleading. According to the Environmental Protection Agency (EPA), the only meaningful way to measure the efficacy of an insect repellent is to test it under realistic conditions. The EPA's FIFRA (Federal Insecticide, Fungicide, and Rodenticide Act) Scientific Advisory Panel, on which Dr. Day served, concluded that cage studies "are not a valid substitute for repellent field studies" and recommended that "only field studies be used to establish efficacy."2 The DEET (N,N-diethyl-m-toluamide, now called N,N-diethyl-3-methylbenzamide) Issues Task Force also contends that "laboratory-derived data poorly predicts field data."3 In addition, the study design used by Fradin and Day did not specify the amount of product applied by each subject. Such an omission makes it impossible to replicate the test and properly interpret the data. In contrast, the product containing IR3535 (ethyl butylacetylaminopropionate) that Fradin and Day tested has been subjected to well-controlled field studies. The results submitted to the EPA demonstrate a protection time for the product of up to three hours or more against mosquitoes. There are no safety concerns associated with the use of IR3535, which is not true of DEET. IR3535 can be formulated with sunscreen, and such combination products offer a twofold public health benefit.


Janice J. Teal, Ph.D.
Avon Products
Suffern, NY 10901

Editor's note: Dr. Teal is group vice-president and chief scientific officer, global research and development, Avon Products. Avon manufactures insect-repellent products for sale in the United States and overseas.

References

  1. Fradin MS, Day JF. Comparative efficacy of insect repellents against mosquito bites. N Engl J Med 2002;347:13-18. [Free Full Text]
  2. Report of the FIFRA Scientific Advisory Panel Meeting, April 5–7, 2000, Arlington, Va. Washington, D.C.: Environmental Protection Agency, August 2000. (Accessed October 30, 2002, at http://www.epa.gov/oscpmont/sap/2000/april/freportapril572000.pdf.)
  3. Letter from Christopher Cathcart, president and chief operating officer for the DEET Issues Task Force of the Chemical Specialties Manufacturers Association, to the Office of Pesticide Programs. Washington, D.C.: Office of Pesticide Programs, Environmental Protection Agency, February 14, 2000.

 
To the Editor: The "arm-in-the-cage tests" employed by Drs. Fradin and Day have been used for over 50 years, but according to the Scientific Advisory Panel of the EPA, such tests should be used only for screening purposes, not for comparative purposes, nor to establish efficacy. According to the EPA, as per the Scientific Advisory Panel, field tests are the only method of determining the efficacy of a repellent.

In addition, the amount of material applied and the concentration used can account for significant differences in the results. One of the products tested was Skin-So-Soft Bath Oil, which is not a repellent.

Both the published information on DEET-based repellents and the information in the mass-media promotion state that the repellents can be relied on to provide prolonged protection in environments where mosquito-borne diseases are a significant threat. This is a false assumption and has never been proved. These statements are also harmful, since laypeople are given a false sense of security, believing that if they use a DEET-based repellent, they will be totally protected from arthropod-borne pathogens. The Scientific Advisory Board of the EPA also agreed that no manufacturer of repellents could make such a statement of protection from mosquito-borne diseases.


Eugene J. Gerberg, Ph.D.
University of Florida
Gainesville, FL 32611


Robert J. Novak, Ph.D.
Illinois Natural History Survey
Champaign, IL 61820

Editor's note: Drs. Gerberg and Novak served on the EPA's Scientific Advisory Panel on repellents.


 
To the Editor: As a physician and a resident of "bush" Alaska, I am a regular user of 95 percent DEET insect repellent and so are many of my associates. Drs. Fradin and Day failed to include in their study a repellent with a DEET concentration greater than 23.8 percent. What was the reason for this?

It would be useful to know whether the highest concentrations offer a significant benefit over those studied. Although the health risks of 95 percent DEET may be minimal, the risk of damage to plastic watches, pens, and camera bodies might be lessened with lower concentrations.


Steve Gerrish, M.D.
Bristol Bay Area Health Corporation
Dillingham, AK 99576
stevegerrish{at}yahoo.com


 
To the Editor: Fradin and Day state, "Until a better repellent becomes available, DEET-based repellents remain the gold standard of protection under circumstances in which it is crucial to be protected against arthropod bites that might transmit disease." In their accompanying Perspective, Pollack and colleagues state, "concentrated DEET formulations (>=35 percent) may be appropriate for those who are exposed for many hours to numerous black flies or mosquitoes or who work in tick-infested areas."1 We agree that DEET is preferred for preventing bites from black flies or mosquitoes, but permethrin has been proved to be more effective for ticks.2,3,4 The effect of permethrin is predominantly acaricidal rather than repellent.3,4 Although it can be safely applied to the skin, permethrin remains effective longer when applied to clothing, netting, or tents and can withstand several washings.2,3,4 In the U.S. military, the concurrent application of DEET repellent on the skin and permethrin on the battle dress uniform is officially known as the DOD (Department of Defense) Insect Repellent System. This combination provides the best-known protection against arthropod bites and the transmission of arthropod-borne diseases to troops in the field.4


David R. Adams, M.D., Pharm.D.
Bryan E. Anderson, M.D.
Christie T. Ammirati, M.D.
Penn State Milton S. Hershey Medical Center
Hershey, PA 17033
dadams{at}psu.edu

References

  1. Pollack RJ, Kiszewski AE, Spielman A. Repelling mosquitoes. N Engl J Med 2002;347:2-3. [Free Full Text]
  2. Mafong EA, Kaplan LA. Insect repellents: what really works? Postgrad Med 1997;102:63, 68-9, 74. 
  3. Brown M, Hebert AAA. Insect repellents: an overview. J Am Acad Dermatol 1997;36:243-249. [CrossRef][ISI][Medline]
  4. Young GD, Evans S. Safety and efficacy of DEET and permethrin in the prevention of arthropod attack. Mil Med 1998;163:324-330. [Medline]

 
To the Editor: Fradin and Day compared the efficacy of DEET and non-DEET insect repellents. It is unfortunate that they ignored a much better repellent — that is, 100 mg of vitamin B1 (1000 times the vitamin dose). It is taken orally and is effective for many hours. (Pharmacokinetic studies are needed.) The repellent effect is attributed to a foul odor, undetected by humans, unless one smells the bottle. Biting insects, which are attracted by carbon dioxide, are repelled. Mosquitoes, deer flies, horse flies, and chiggers are repelled. It is not known whether arachnids are repelled, although deer ticks seem to be.

Not only is vitamin B1 much less expensive than other repellents, but it also is nonwetting, is not oily, and is not rubbed off on clothes.


Stewart C. Harvey, Ph.D.
900 S. Donner Way, #404
Salt Lake City, UT 84108


 
To the Editor: A product not mentioned in Fradin and Day's article is Bayrepel, Bayer's trade name for a piperidine derivative that the company has developed. Bayer claims that the action of this product equals or exceeds that of DEET. (The company's Web site shows convincing evidence based on comparative testing against various arthropods.) Bayrepel is the active ingredient in their Autan line of insect-repellent products. Although this product may not be available in the United States (I suspect Fradin and Day would have tested it if it were), Autan products are widely used in Germany and Austria, probably throughout the European Union, and perhaps elsewhere in the world. It is good to know that a product commonly available to those of us outside the United States is effective.


George Brownstone, M.D.
Girardigasse 3/23
A 1060 Vienna, Austria
georg.brownstone{at}chello.at


 
The authors reply:

To the Editor: Teal is correct that the recommendation of the EPA's Scientific Advisory Panel (in April 2000) was that "only field studies be used to establish efficacy and subsequent registration"1 of new repellents. Teal neglects to mention, however, that the panel also stated that cage studies "can be used to compare products."1 In our article, we explained the rationale for using the arm-in-cage method. It would have been impossible to conduct a valid comparative field study of this size, given the multiple environmental variables that affect biting rates. With West Nile virus now found throughout the United States, the ethics of requiring field trials may need to be examined by the EPA, which has not yet adopted the recommendations of the panel.

Our decision not to standardize the amount of repellent each subject applied was deliberate. We wanted our study to reflect real-life usage, and application quantities are not stated on repellent labels. In our experience, repellents are typically overapplied, not underapplied, so we are confident that our subjects applied sufficient quantities of repellent to make it possible to judge each one's relative efficacy.

Gerberg and Novak properly emphasize that persons should not rely solely on insect repellents for the prevention of insect bites and insect-borne diseases. As we stated twice in our article, "Protection from arthropod bites is best achieved by avoiding infested habitats, wearing protective clothing, and using insect repellent." We agree with Adams et al. that the combined use of the contact insecticide permethrin on clothing and DEET on the skin results in a formidable barrier, providing a level of protection against mosquito bites as high as 99.9 percent, even under conditions in which unprotected subjects received an average of 1188 bites per hour.2

Gerrish asks why we did not test products containing more than 23.8 percent DEET. Other than a few 95 percent DEET products, all DEET products on the U.S. market contain 40 percent DEET or less. DEET's duration of action tends to plateau at concentrations higher than 50 percent, so relatively little additional benefit is afforded by 95 percent DEET. Given that we found a mean protection time of five hours for 23.8 percent DEET,3 adequate protection can be achieved by using products with lower concentrations and reapplying the repellent as needed.

Like Harvey, we would like the convenience of having an effective oral arthropod repellent. Unfortunately, vitamin B1 has been proved to be ineffective.4

Brownstone mentions a piperidine-based repellent, Bayer's Bayrepel. This repellent has been available in Europe since 1998 and was registered with the EPA in 2000 but is not yet available in the United States. If it proves to provide protection against mosquito bites for two to eight hours (as stated in Bayer's literature5), it may well provide repellent action similar to that of DEET.

We should have noted in our article that Dr. Day was an expert witness for S.C. Johnson, maker of OFF insect repellents, in April 2002. We apologize for the oversight.


Mark S. Fradin, M.D.
Chapel Hill Dermatology
Chapel Hill, NC 27514
mark_fradin{at}med.unc.edu


Jonathan F. Day, Ph.D.
Florida Medical Entomology Laboratory
Vero Beach, FL 32962

References

  1. Report of the FIFRA Scientific Advisory Panel Meeting, April 5–7, 2000, Arlington, Va. Washington, D.C.: Environmental Protection Agency, August 2000. (Accessed October 30, 2002, at http://www.epa.gov/oscpmont/sap/2000/april/freportapril572000.pdf.)
  2. Lillie TH, Schreck CE, Rahe AJ. Effectiveness of personal protection against mosquitoes in Alaska. J Med Entomol 1988;25:475-478. [ISI][Medline]
  3. Fradin MS, Day JF. Comparative efficacy of insect repellents against mosquito bites. N Engl J Med 2002;347:13-18. [Free Full Text]
  4. Khan AA, Maibach HI, Strauss WG, Fenley WR. Vitamin B1 is not a systemic mosquito repellent in man. Trans St Johns Hosp Dermatol Soc 1969;55:99-102. [Medline]
  5. Autan information. Leverkusen, Germany: Bayer AG, 2002. (Accessed October 30, 2002, at http://www.autan.com/scientific-e.html.)

 

This Article
- PDF
-PDA Full Text

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Pollack, R. J.
-Related Article
 by Fradin, M. S.
-PubMed Citation


HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.